Keyword: Alex Gorsky

As J&J continues to defend against allegations its talc powders can cause cancer, it prevailed in a South Carolina trial and lost in New York on Tuesday.

With resolutions on the ballot at six top U.S. drugmakers, investors aim to learn how drug pricing affects executive pay.

What does it take to run one of pharma’s biggest whales? As J&J CEO Alex Gorsky told Fortune, six years in the U.S. Army made all the difference.

Johnson & Johnson hit—and exceeded—all its financial goals in 2018. So why did its top executive take a $9 million-plus pay cut?

J&J has been battling lawsuits and damaging headlines over its talc powder, and now a senator is getting involved.

J&J's CEO said this week the pharma industry needs to police itself on pricing. Days later, his company raised prices on two dozen drugs.

What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says.

Investors sent J&J's shares down Friday after Reuters reported on court documents detailing the company's internal debates over asbestos in talc.

J&J CEO Alex Gorsky said Amazon could offer expertise in distribution as well as shake up reimbursement in a potential pharma entry.